Clinical Research Directory
Browse clinical research sites, groups, and studies.
Faecal Microbiota Transplantation for Liver Cirrhosis
Sponsor: University of Aarhus
Summary
The purpose is to investigate the effect of faecal microbiota transplantation (FMT) on complications, progression, and mortality of patients with liver cirrhosis. Further, the investigators want to examine the impact of FMT on the gut microbiota, gut barrier function, systemic inflammation, and immune function.
Official title: Faecal Microbiota Transplantation to Prevent Complications, Progression and Mortality of Liver Cirrhosis
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2021-07-01
Completion Date
2027-05-31
Last Updated
2025-01-24
Healthy Volunteers
No
Conditions
Interventions
Faecal microbiota transplantation
All participant will receive three applications of either FMT or placebo and afterwards followed for 1 year.
Placebo
Placebo
Locations (1)
Department of Hepatology and Gastroenterology, Aarhus University Hospital
Aarhus, Denmark